Literature DB >> 18981303

Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells.

Shoukang Zhu1, Sarah Evans, Bin Yan, Thomas J Povsic, Victor Tapson, Pascal J Goldschmidt-Clermont, Chunming Dong.   

Abstract

BACKGROUND: Endothelial progenitor cells (EPCs) contribute to vascular regeneration/repair and thus may protect against scleroderma vasculopathy. We aimed to determine whether circulating EPCs were reduced in scleroderma, whether scleroderma sera could induce EPC apoptosis, and, if so, what the underlying apoptotic signaling pathway was. METHODS AND
RESULTS: Circulating EPC levels were quantified in 54 patients with scleroderma and 18 healthy control subjects by colony-forming unit assay and flow cytometry, which revealed markedly decreased EPC levels in scleroderma patients relative to healthy subjects. Substantial apoptosis was detected in EPCs after culturing in the presence of scleroderma sera compared with normal sera. Intriguingly, depletion of the IgG fraction from scleroderma sera completely abolished the apoptotic effects. Furthermore, scleroderma sera inhibited the activation/phosphorylation of Akt, which in turn suppressed the phosphorylation and degradation of forkhead transcription factor FKHRL1 (FOXO3a), resulting in the upregulation of apoptotic protein Bim. siRNA-mediated FOXO3a and Bim knockdown substantially reduced scleroderma serum-induced EPC apoptosis. Importantly, Bim expression and baseline apoptosis were increased in EPCs freshly isolated from scleroderma patients relative to that obtained from healthy subjects.
CONCLUSIONS: Scleroderma serum-induced EPC apoptosis is mediated chiefly by the Akt-FOXO3a-Bim pathway, which may account, at least in part, for the decreased circulating EPC levels in scleroderma patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981303      PMCID: PMC3719010          DOI: 10.1161/CIRCULATIONAHA.108.787200

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

1.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

Authors:  Jonathan M Hill; Gloria Zalos; Julian P J Halcox; William H Schenke; Myron A Waclawiw; Arshed A Quyyumi; Toren Finkel
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

2.  Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis.

Authors:  Jin Hur; Chang-Hwan Yoon; Hyo-Soo Kim; Jin-Ho Choi; Hyun-Jae Kang; Kyung-Kook Hwang; Byung-Hee Oh; Myoung-Mook Lee; Young-Bae Park
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-29       Impact factor: 8.311

3.  Defective vasculogenesis in systemic sclerosis.

Authors:  Masataka Kuwana; Yuka Okazaki; Hidekata Yasuoka; Yutaka Kawakami; Yasuo Ikeda
Journal:  Lancet       Date:  2004 Aug 14-20       Impact factor: 79.321

4.  Progress in research into systemic sclerosis.

Authors:  Bashar Kahaleh
Journal:  Lancet       Date:  2004 Aug 14-20       Impact factor: 79.321

Review 5.  Raynaud's phenomenon and the role of capillaroscopy.

Authors:  Maurizio Cutolo; Walter Grassi; Marco Matucci Cerinic
Journal:  Arthritis Rheum       Date:  2003-11

6.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

7.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP.

Authors:  Carsten Skurk; Henrike Maatz; Hyo-Soo Kim; Jiang Yang; Md Ruhul Abid; William C Aird; Kenneth Walsh
Journal:  J Biol Chem       Date:  2003-10-08       Impact factor: 5.157

10.  Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity.

Authors:  J Avouac; F Juin; J Wipff; P O Couraud; G Chiocchia; A Kahan; C Boileau; G Uzan; Y Allanore
Journal:  Ann Rheum Dis       Date:  2008-01-03       Impact factor: 19.103

View more
  31 in total

Review 1.  Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.

Authors:  Maria Trojanowska
Journal:  Nat Rev Rheumatol       Date:  2010-06-29       Impact factor: 20.543

Review 2.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 3.  Atherosclerosis, inflammation, genetics, and stem cells: 2012 update.

Authors:  Pascal J Goldschmidt-Clermont; Chunming Dong; David M Seo; Omaida C Velazquez
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

4.  Upregulated expression of NF-YC contributes to neuronal apoptosis via proapoptotic protein bim in rats' brain hippocampus following middle cerebral artery occlusion (MCAO).

Authors:  Yunfeng Wang; Chunhua Wan; Shanshan Yu; Lixiang Yang; Bing Li; Ting Lu; Yongfeng Bi; Junkang Jiang; Gang Cui
Journal:  J Mol Neurosci       Date:  2013-09-08       Impact factor: 3.444

5.  The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway.

Authors:  Lukasz Stawski; Grace Marden; Maria Trojanowska
Journal:  J Immunol       Date:  2017-11-15       Impact factor: 5.422

6.  CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma.

Authors:  Megan E Murray; Catherine M Gavile; Jayakumar R Nair; Chandana Koorella; Louise M Carlson; Daniela Buac; Adam Utley; Marta Chesi; P Leif Bergsagel; Lawrence H Boise; Kelvin P Lee
Journal:  Blood       Date:  2014-04-29       Impact factor: 22.113

7.  S6 kinase 2 promotes breast cancer cell survival via Akt.

Authors:  Savitha Sridharan; Alakananda Basu
Journal:  Cancer Res       Date:  2011-03-22       Impact factor: 12.701

8.  An Autoimmune Basis for Raynaud's Phenomenon: Murine Model and Human Disease.

Authors:  D P Ascherman; Y Zang; I Fernandez; E S Clark; W N Khan; L Martinez; E L Greidinger
Journal:  Arthritis Rheumatol       Date:  2018-07-25       Impact factor: 10.995

Review 9.  Endothelial progenitor cell dysfunction in rheumatic disease.

Authors:  Peter E Westerweel; Marianne C Verhaar
Journal:  Nat Rev Rheumatol       Date:  2009-06       Impact factor: 20.543

10.  Scleroderma dermal microvascular endothelial cells exhibit defective response to pro-angiogenic chemokines.

Authors:  Pei-Suen Tsou; Bradley J Rabquer; Ray A Ohara; William A Stinson; Phillip L Campbell; M Asif Amin; Beatrix Balogh; George Zakhem; Paul A Renauer; Ann Lozier; Eshwar Arasu; G Kenneth Haines; Bashar Kahaleh; Elena Schiopu; Dinesh Khanna; Alisa E Koch
Journal:  Rheumatology (Oxford)       Date:  2015-12-24       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.